A detailed history of Inceptionr LLC transactions in Geron Corp stock. As of the latest transaction made, Inceptionr LLC holds 10,707 shares of GERN stock, worth $11,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,707
Previous 15,078 28.99%
Holding current value
$11,991
Previous $21.3 Million 31.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$1.1 - $1.47 $4,808 - $6,425
-4,371 Reduced 28.99%
10,707 $14.7 Million
Q2 2025

Aug 12, 2025

SELL
$1.18 - $1.62 $2,572 - $3,531
-2,180 Reduced 12.63%
15,078 $21.3 Million
Q1 2025

May 12, 2025

BUY
$1.59 - $3.6 $27,440 - $62,128
17,258 New
17,258 $27.4 Million
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $46,655 - $76,604
15,050 New
15,050 $63.8 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $423M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.